Blood Pressure First Medication Therapy Management (BP First)

Evaluation of the Impact of Self-insured Employer Implementation of an Innovative Care Model Utilizing Pharmacist-delivered MTM Services for Health Plan Beneficiaries With High Blood Pressure

The primary objective of this project is to improve the health status of participants through pharmacist-delivered blood pressure control programs that demonstrate value to employers and justify adoption, sustainability and scalability of these programs.

Study Overview

• Status: Completed
• Conditions: Cardiovascular Diseases; Hypertension; Blood Pressure
• Intervention / Treatment: Behavioral: Health Management; Blood Pressure

Detailed Description

Univariate comparisons of the baseline/pre-intervention outcomes to the post-intervention outcomes will be performed on outcomes in order to determine how the intervention affects each. For continuous outcomes data the univariate comparisons of the pre-treatment and post-intervention outcomes will be performed using related samples t-test comparisons. For categorical outcomes data, comparisons of pre-intervention to post-intervention time frames will be performed using McNemar tests.

• Study Type: Observational
• Enrollment (Actual): 27

Contacts and Locations

Study Locations

• United States
  • Georgia
    • Woodstock, Georgia, United States, 30188
      • Woodstock Pharmaceutical & Compounding Center Inc.

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Beneficiaries of self-insured employer who may benefit from patient-centered, team-based care that supports blood pressure control.

Description

Inclusion Criteria:

• All health plan beneficiaries 18 years-of-age and older
• Have filled at least one blood pressure medication in the last three months,
• Have a known hypertension diagnosis or have an uncontrolled blood pressure

Exclusion Criteria:

• Not an adult
• Not a health plan beneficiary of the self-insured employer
• Not ambulatory and able to work or participate in care visits

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Cohort; This project will evaluate the impact of self-insured employers implementing an innovative care model utilizing pharmacist-delivered MTM services for health plan beneficiaries with high blood pressure.	Behavioral: Health Management; Blood Pressure; Pharmacists will work with the patient/study subject, referred to as the participant hereafter, and the participant's other health care providers to manage their blood pressure, making recommendations for medication and lifestyle adjustments as needed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Blood Pressure Control	Management of Systolic and Diastolic Blood Pressure Measures	6-months
Blood Pressure Change	Systolic and Diastolic Blood Pressure Measure Changes	6-months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Blood Pressure Medication Adherence	Medication Adherence for Blood Pressure Medications as Measured by Proportion of Days Covered (PDC)	6-months
Health Care Utilization of Primary Care Services	Evaluation of Pre- and Post-Intervention Frequency of Primary Health Care Visits	6-months
Health Care Utilization of Emergency Department Services	Evaluation of Pre- and Post-Intervention Frequency Emergency Department Visits	6-months
Health Care Utilization of Hospital Services	Evaluation of Pre- and Post-Intervention Frequency of Hospital Visits	6-months

Collaborators and Investigators

• Sponsor: American Pharmacists Association Foundation
• Investigators: Principal Investigator: Benjamin M Bluml, RPh, APhA Foundation

Study record dates

Study Major Dates

• Study Start (Actual): February 6, 2020
• Primary Completion (Actual): July 31, 2020
• Study Completion (Actual): December 31, 2020

Study Registration Dates

• First Submitted: February 14, 2020
• First Submitted That Met QC Criteria: February 17, 2020
• First Posted (Actual): February 19, 2020

Study Record Updates

• Last Update Posted (Estimate): February 21, 2023
• Last Update Submitted That Met QC Criteria: February 18, 2023
• Last Verified: February 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases
• Other Study ID Numbers: 020

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No